Phenominer Database Results (6 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Method Notes Clinical Measurement Notes Record ID Study ID
DA.PVG.1AV1-(D4Got211-D4Mit12)/Kini percentage of study population developing experimental autoimmune encephalomyelitis during a period of time myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 40 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female 0 days 16 38.0 % in vivo visual assessment 0.0 subcutaneous injection 40 days from 8 to 40 days 69387 892
DA.PVG.1AV1-(D4Got211-D4Mit12)/Kini post-insult time to onset of experimental autoimmune encephalomyelitis myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 40 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female 0 days 16 33.9 d in vivo visual assessment 0.0 subcutaneous injection 0 from 8 to 40 days 69388 892
DA.PVG.1AV1-(D4Got211-D4Mit12)/Kini post-insult time to onset of experimental autoimmune encephalomyelitis myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 31 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female 0 days 19 15.8 d in vivo visual assessment 0.0 subcutaneous injection 0 from 8 to 31days days 69398 892
DA.PVG.1AV1-(D4Got211-D4Mit12)/Kini percentage of study population developing experimental autoimmune encephalomyelitis during a period of time myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 31 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female 0 days 19 100.0 % in vivo visual assessment 0.0 subcutaneous injection 31 days from 8 to 31days 69397 892
DA.PVG.1AV1-(D4Got211-D4Mit12)/Kini experimental autoimmune encephalomyelitis duration myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 40 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female 0 days 16 4.9 d in vivo visual assessment 0.0 subcutaneous injection 40 days from 8 to 40 days days 69389 892
DA.PVG.1AV1-(D4Got211-D4Mit12)/Kini experimental autoimmune encephalomyelitis duration myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 31 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female 0 days 19 11.8 d in vivo visual assessment 0.0 subcutaneous injection 31 days from 8 to 31days days 69399 892